Showing 1 - 10 of 135
Purpose – Public sector interest in methods for priority setting and program or policy evaluation has grown considerably over the last several decades, given increased expectations for accountable and efficient use of resources and emphasis on evidence‐based decision making as a component of...
Persistent link: https://ebvufind01.dmz1.zbw.eu/10014872280
Persistent link: https://ebvufind01.dmz1.zbw.eu/10010015152
Persistent link: https://ebvufind01.dmz1.zbw.eu/10009663459
This comprehensive collection brings together more than 50 contributions from some of the most influential researchers in health economics. It authoritatively covers theoretical and empirical issues in health economics, with a balanced range of material on equity and efficiency in health care...
Persistent link: https://ebvufind01.dmz1.zbw.eu/10011176298
ABSTRACT A major driver of cost growth in health care is the rapid increase in the utilisation of existing technology and not simply the adoption of new technology. Health economists and their health technology assessment colleagues have become obsessed by technology adoption questions and have...
Persistent link: https://ebvufind01.dmz1.zbw.eu/10011005304
Persistent link: https://ebvufind01.dmz1.zbw.eu/10011304931
Background: Variation exists in quality of life (i.e., utility) estimates depending on the utility elicitation method utilized. Using the EQ-5D, VAS, and HUI-III, the aim of this thesis was to determine whether these measures adequately capture HRQOL in a CRC population and assess the...
Persistent link: https://ebvufind01.dmz1.zbw.eu/10009455391
The principal aim of this article is to share lessons learned by the authors while conducting economic evaluations, using clinical trial data, of mental health interventions. These lessons are quite general and have clear relevance for pharmacoeconomic studies. In addition, we explore how net...
Persistent link: https://ebvufind01.dmz1.zbw.eu/10010848972
Canada has a separate review process for making cancer drug funding recommendations, and this process uses both clinical and economic evidence. The committee could not determine the value for money of the drugs from several of the submitted pharmacoeconomic analyses. Transparent analyses and...
Persistent link: https://ebvufind01.dmz1.zbw.eu/10011001661
This paper reports on the design, implementation, and results of a structured public deliberation on human tissue biobanking conducted in Vancouver, Canada, in 2009. This study builds on previous work on the use of deliberative democratic principles and methods to engage publics on the social...
Persistent link: https://ebvufind01.dmz1.zbw.eu/10010582553